Advertisement

Related Videos

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Varsha Gandhi, PhD, on Ibrutinib

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Advertisement

Advertisement




Dec
18
Today In Oncology
CD123-Targeting ADC Shows Activity in AML and BPDCN
Data Published on Incidence of Immune Checkpoint Inhibitor-Associated ITP
Gemcitabine Intravesical System Shows High Disease-Free Survival Rates in BCG-Unresponsive Papillary-Only NMIBC
Neoadjuvant SABR Improves Outcomes in Patients With RCC and IVC Tumor Thrombus
Lymphocyte Kinetics After CAR T Infusion Predict Survival Outcomes in Non-Hodgkin Lymphoma
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo